Sign in

Private company

디엑스앤브이엑스

디엑스앤브이엑스 is a South Korean company.1 Its revenue was ₩33.9 billion in 2024.1

디엑스앤브이엑스(Dx&Vx)는 백신 · 바이오 신약 및 마이크로바이옴 기반의 맞춤형 치료 균주 연구 개발 등 CDO, CRO, CMO, CSO 비즈니스를 영위하는 바이오 헬스케어 기업이다.2 From the Korean Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

See how the biggest companies compare on our leaderboards

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

  • 202433.9B KRW1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2